基于患者对癌症疼痛药物治疗知识熟悉度的影响因素调查

Investigation on Influencing Factors Based on Patient’s Familiarity with Medical Treatment Knowledge of Cancer Pain

目的了解癌症疼痛(简称癌痛)患者对药物治疗知识的熟悉度及其相关影响因素,为患者癌痛药物治疗管理提供依据。方法采用整群抽样方法抽取湖北省7家医院癌痛患者394例,针对患者基本情况及其对药物的用法用量、储存保管、注意事项、不良反应和依赖性等熟悉度进行问卷调查;运用卡方检验、二元Logistic回归法进行统计分析。结果共收到有效问卷372份,多数患者的付费类型为新型农村合作医疗和医疗保险;56.5%患者疼痛时间超过1个月;>60%患者对癌痛药物治疗知识很熟悉。患者文化程度、付费类型、家庭收入和疼痛时间与癌痛药物治疗知识熟悉度差异有统计学意义(P<0.05或P<0.01)。进一步回归分析结果显示,文化程度、性别、家庭收入和疼痛时间是患者对癌痛药物治疗知识熟悉度的影响因素。结论患者对癌痛药物治疗知识的熟悉度受到多种因素影响,应针对性开展癌痛及镇痛药物相关知识的教育项目,提高患者对癌痛药物治疗的认知,进一步改善癌痛患者的药物治疗管理。

Objective To understand the familiarity and related influencing factors of patients with cancer pain with medical treatment knowledge,and to provide reference for medical treatment management of cancer pain.Methods A total of 394 patients with cancer pain in 7 hospitals in Hubei province were investigated by cluster sampling.Questionnaire survey was conducted on the basic characteristics of the patients and their familiarity of drug usage,dosage,storage,precautions,side effects and dependence.Chi-square test and binary logistic regression were used for statistical analysis.Results A total of 372 effective questionnaires were received,and most of the patients’payment types were the new rural cooperative medical system(NCMS)and medical insurance.The proportion of patients suffered pain more than one month was 56.5%,and more than 60%of patients were familiar with medical treatment knowledge for cancer pain.There were statistically significant differences in patients’education level,payment type,family income and pain time with the familiarity of cancer pain medication knowledge(P<0.05 or P<0.01).Further regression analysis showed that education level,gender,family income and pain time were the influencing factors of patients’familiarity with cancer pain medication knowledge.Conclusion The patient’s familiarity with medical treatment knowledge of cancer pain is affected by many factors,thus education project on cancer pain and analgesics knowledge should be carried out to improve the patient’s cognition and the management of cancer pain medication.